Beike Biotech   Report issue

For profit Phase 1 Phase 2
Founded: Shenzhen China (2001)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2009
NCT01343511
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Beike Biotech India Pvt.ltd | CytoMed & Beike | Shenzhen Beike Bio-Technology Co., Ltd.